Endocrinology

Help Shape the Future of Denosumab Treatment

As biosimilars enter the denosumab landscape, your perspective as a healthcare provider is critical in understanding what factors influence treatment decisions. This brief survey explores your views on reimbursement considerations, coding challenges, switching comfort, and drivers of biosimilar choice. As a thank you, by completing the survey, you’ll be entered into a drawing for a chance to win a $200 gift card.

Take the survey now and make your voice heard

Latest News

Perimenopause Misdiagnosis Affects Nearly 40% of Women as Healthcare System Fails to Address Hormonal Roots
Perimenopause Misdiagnosis Affects Nearly 40% of Women as Clinicians Fail to Recognize Hormonal Transition

November 14th 2025

Nearly 40% of perimenopausal women report misdiagnosis as clinicians treat for anxiety and depression without addressing underlying hormonal imbalance.

Cushing Syndrome: A Primer for Primary Care Clinicians / image credit ©Vitalii Vodolazskyi/stock.adobe.com
Cushing Syndrome: Clinical Features, Screening Tests, and When to Refer

November 11th 2025

Workplace Diabetes Support Checklist for Clinicians / image credit ©kenishirotie/stock.adobe.com
Diabetes Self-Management at Work: A Checklist for Clinicians

November 7th 2025

Administration Anounces Landmark GLP-1 Pricing Agreement with Eli Lilly and Novo Nordisk / image ©K KStock/stock.adobe.com
Administration Anounces Landmark GLP-1 Pricing Agreement with Eli Lilly and Novo Nordisk

November 6th 2025

Oral Semaglutide 25 mg Shows Cardiometabolic Benefits Beyond Weight Loss in OASIS 4 Analysis / image credit ©CLIPAREA_media/Shutterstock.com
Oral Semaglutide 25 mg Shows Cardiometabolic Benefits Beyond Weight Loss in OASIS 4 Analysis

November 6th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.